Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females

Gender Medicine

Volumn 5, Issue SUPPL. 1, 2008, Pages

  Carlson, Scott ^a,b   Peng, Ning ^a   Prasain, Jeevan K ^c   Wyss, J Michael ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b LUTHER COLLEGE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

blood pressure; diabetes; estrogen; hypertension; lipids; menopause

Indexed keywords

CATECHIN; DAIDZEIN; EPICATECHIN; ESTROGEN; GENISTEIN; GLYCOSYLATED HEMOGLOBIN; GRAPE SEED EXTRACT; INSULIN; ISOFLAVONE DERIVATIVE; KUDZU EXTRACT; LIPID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; PUERARIA LOBATA EXTRACT; SOYBEAN OIL; UNCLASSIFIED DRUG;

AGING; ARTERIAL PRESSURE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CAROTID ARTERY FLOW; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CORONARY ARTERY BLOOD FLOW; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLYCEMIC CONTROL; HEART DISEASE; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; MEDLINE; MENOPAUSAL SYNDROME; METABOLIC DISORDER; METABOLISM; POSTMENOPAUSE; PRIORITY JOURNAL; PUERARIA LOBATA; SYMPTOM;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; COGNITION; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; GENISTEIN; HUMANS; ISOFLAVONES; MALE; PHENOLS; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; PROANTHOCYANIDINS; PUERARIA; SOYBEAN PROTEINS; VASOCONSTRICTION;

EID: 41449115158     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genm.2008.03.008     Document Type: Article

References (107)

1. Cohen E., Wheat M., Swiderski D., et al. Hypertension in women. In: Laragh J., and Brenner B. (Eds). Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. (1995), Lippincott Williams & Wilkins, Philadelphia, Pa 159-169
2. Ledingham JM. The vascular fault in hypertension: Byrom's work revisited. In: Laragh J., and Brenner B. (Eds). Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. (1995), Lippincott Williams & Wilkins, Philadelphia, Pa: 37-53
3. Wilson P., and Kannel WB. Hypertension, other risk factors, and the risk of cardiovascular disease. In: Laragh J., and Brenner B. (Eds). Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. (1995), Lippincott Williams & Wilkins, Philadelphia, Pa 99-114
4. Du X., Fang L., and Kiriazis H. Sex dimorphism in cardiac pathophysiology: Experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 111 (2006) 434-475
5. Kotchen J., McKean H., and Kotchen TA. Blood pressure trends with aging. Hypertension. 4 (1982) III128-III134
6. Spence JD. Cerebral consequences of hypertension: Where do they lead?. J Hypertens Suppl. 14 (1996) S139-S145
7. Grodstein F., and Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38 (1995) 199-210
8. Nabulsi A., Folsom A., White A., et al., for the Atherosclerosis Risk in Communities Study Investigators. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328 (1993) 1069-1075
9. Grodstein F., Manson J., Colditz G., et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133 (2000) 933-941
10. Gouva L., and Tsatsoulis A. The role of estrogens in cardiovascular disease in the aftermath of clinical trials. Hormones (Athens) 3 (2004) 171-183
11. Barrett-Connor E. Hormones and the health of women: Past, present, and future. Keynote address. Menopause 9 (2002) 23-31
12. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 274 (1995) 1676
13. JAMA. 273 (1995) 199-208
14. Hulley S., Grady D., Bush T., et al., For the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
15. Rossouw J., Anderson G., Prentice R., et al., For the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
16. Radimer K., Bindewald B., Hughes J., et al. Dietary supplement use by US adults: Data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160 (2004) 339-349
17. Radimer KL. National nutrition data: Contributions and challenges to monitoring dietary supplement use in women. J Nutr. 133 (2003) 2003S-2007S
18. Gordon N., and Schaffer D. Use of dietary supplements by female seniors in a large Northern California health plan. BMC Geriatr 5 (2005) 4
19. Farnsworth N., Akerele O., Bingel A., et al. Medicinal plants in therapy. Bull World Health Organ 63 (1985) 965-981
20. Geller S., and Studee L. Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 14 3 Pt 1 (2007) 541-549
21. Newton K., Reed S., Lacroix A., et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: A randomized trial. Ann Intern Med 145 (2006) 869-879
22. Spangler L., Newton K., Grothaus L., et al. The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin. Maturitas 57 (2007) 195-204
23. Wuttke W., Jarry H., and Seidlova-Wuttke D. Isoflavones-safe food additives or dangerous drugs?. Ageing Res Rev. 6 (2007) 150-188
24. Unfer V., Casini M., Costabile L., et al. Endometrial effects of long-term treatment with phytoestrogens: A randomized, double-blind, placebo-controlled study. Fertil Steril 82 (2004) 145-148
25. Fleming R. The effect of ephedra and high fat dieting: A cause for concern! A case report. Angiology 58 (2007) 102-105
26. Libman R., Menna B., and Gulati S. Case report: Consequences of ephedra use in an athlete. Lancet 366 Suppl 1 (2005) S22
27. Fava M., Alpert J., Nierenberg A., et al. A doubleblind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol 25 (2005) 441-447
28. Kliewer S., and Willson T. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43 (2002) 359-364
29. Moore L., Goodwin B., Jones S., et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97 (2000) 7500-7502
30. Staudinger J., Ding X., and Lichti K. Pregnane X receptor and natural products: Beyond drug-drug interactions. Expert Opin Drug Metab Toxicol 2 (2006) 847-857
31. Witte S., Loew D., and Gaus W. Metaanalysis of the efficacy of the acetonic kavakava extract WS1490 in patients with nonpsychotic anxiety disorders. Phytother Res 19 (2005) 183-188
32. Clouatre D. Kava kava: Examining new reports of toxicity. Toxicol Lett 150 (2004) 85-96
33. Anderson J., Johnstone B., and Cook-Newell M. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333 (1995) 276-282
34. Demonty I., Lamarche B., and Jones P. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 61 6 Pt 1 (2003) 189-203
35. Demonty I., Lamarche B., Deshaies Y., et al. Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem 13 (2002) 671-677
36. Merz-Demlow B., Duncan A., Wangen K., et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71 (2000) 1462-1469
37. Wangen K., Duncan A., Xu X., and Kurzer M. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73 (2001) 225-231
38. Taku K., Umegaki K., Sato Y., et al. Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85 (2007) 1148-1156
39. Allen J., Becker D., Kwiterovich P., et al. Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women. Menopause 14 (2007) 106-114
40. Welty F., Lee K., Lew N., and Zhou JR. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med. 167 (2007) 1060-1067
41. Crawford P., Paden S., and Park MK. Clinical inquiries: What is the dietary treatment for low HDL cholesterol?. J Fam Pract. 55 (2006) 1076-1078
42. Teede H., Dalais F., Kotsopoulos D., et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: A placebocontrolled study in men and postmenopausal women. J Clin Endocrinol Metab 86 (2001) 3053-3060
43. Nagata C., Shimizu H., Takami R., et al. Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Prev Med 36 (2003) 692-697
44. Nakamura M., Aoki N., Yamada T., et al. Feasibility and effect on blood pressure of 6-week trial of low sodium soy sauce and miso (fermented soybean paste). Circ J 67 (2003) 530-534
45. Greaves K., Parks J., Williams J., and Wagner J. Intact dietary soy protein, but not adding an isoflavonerich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 129 (1999) 1585-1592
46. Fang Z., Carlson S., Chen Y., et al. Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1934-R1939
47. Martin D., Breitkopf N., Eyster K., and Williams J. Dietary soy exerts an antihypertensive effect in spontaneously hypertensive female rats. Am J Physiol Regul Integr Comp Physiol 281 (2001) R553-R560
48. Teede H., Giannopoulos D., Dalais F., et al. Randomised, controlled, crossover trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects. J Am Coll Nutr 25 (2006) 533-540
49. Hasler C. The cardiovascular effects of soy products. J Cardiovasc Nurs 16 (2002) 50-63
50. Zhang X., Shu X., Gao Y., et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133 (2003) 2874-2878
51. Yamori Y., and Horie R. Communitybased prevention of stroke: Nutritional improvement in Japan. Health Rep 6 (1994) 181-188
52. Yamori Y. Experimental evidence for dietary prevention of cardiovascular diseases. Clin Exp Pharmacol Physiol 16 (1989) 303-307
53. Clarkson T., Anthony M., and Morgan T. Inhibition of postmenopausal atherosclerosis progression: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86 (2001) 41-47
54. Clarkson TB. Soy phytoestrogens and cardiovascular disease. J Nutr. 132 (2002) 566S-569S
55. Linford N., and Dorsa D. 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67 (2002) 1029-1040
56. Jayagopal V., Albertazzi P., Kilpatrick E., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25 (2002) 1709-1714
57. Kuiper G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
58. Kuiper G., Lemmen J., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
59. Abbas H., Tak H., Boyette C., et al. Macrocyclic trichothecenes are undetectable in kudzu (Pueraria montana) plants treated with a highproducing isolate of Myrothecium verrucaria. Phytochemistry 58 (2001) 269-276
60. Messina M., McCaskill-Stevens W., and Lampe J. Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings. J Natl Cancer Inst 98 (2006) 1275-1284
61. Sakla M., Shenouda N., Ansell P., et al. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine 32 (2007) 69-78
62. Anthony M., Clarkson T., Hughes Jr. C., et al. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126 (1996) 43-50
63. Blair R., Appt S., Bennetau-Pelissero C., et al. Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J Nutr 132 (2002) 3585-3591
64. Washburn S., Burke G., Morgan T., and Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6 (1999) 7-13
65. Goodman-Gruen D., and Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131 (2001) 1202-1206
66. Liang Y., Teede H., Dalais F., et al. The effects of phytoestrogen on blood pressure and lipids in healthy volunteers [Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi 34 (2006) 726-729
67. Bloedon L., Jeffcoat A., Lopaczynski W., et al. Safety and pharmacokinetics of purified soy isoflavones: Singledose administration to postmenopausal women. Am J Clin Nutr 76 (2002) 1126-1137
68. Rivas M., Garay R., Escanero J., et al. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132 (2002) 1900-1902
69. Mahn K., Borras C., Knock G., et al. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19 (2005) 1755-1757
70. Li H., Wang L., and Qu S. Phytoestrogen genistein decreases contractile response of aortic artery in vitro and arterial blood pressure in vivo. Acta Pharmacol Sin 25 (2004) 313-318
71. Wu J., Oka J., Tabata I., et al. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: A 1-year randomized placebocontrolled trial. J Bone Miner Res 21 (2006) 780-789
72. Wu J., Oka J., Higuchi M., et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: A randomized placebocontrolled trial. Metabolism 55 (2006) 423-433
73. Chanawirat A., Khemapech S., Patumraj S., and Siriviriyakul P. Genistein replacement therapy on endothelial dysfunction and bone loss in bilateral ovariectomized rats. Clin Hemorheol Microcirc 34 (2006) 309-314
74. Casini M., Marelli G., Papaleo E., et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: A randomized, double-blind, crossover, placebo-controlled study. Fertil Steril 85 (2006) 972-978
75. Aubertin-Leheudre M., Lord C., Khalil A., and Dionne I. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: A randomized, double-blind study. Menopause 14 (2007) 624-629
76. Wyss J., Liumsiricharoen M., Sripairojthikoon W., et al. Exacerbation of hypertension by high chloride, moderate sodium diet in the saltsensitive spontaneously hypertensive rat. Hypertension. 9 6 Part 2 (1987) III171-III175
77. Calhoun D., Zhu S., Wyss J., and Oparil S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension 24 (1994) 1-7
78. Williams J., Young D., Adams M., et al. Effects of estrogen on cardiovascular responses of premenopausal monkeys. J Pharmacol Exp Ther 271 (1994) 671-676
79. Fisher N., Ferri C., Bellini C., et al. A sexual dimorphism in essential hypertension. Age, gender, and nonmodulation. Hypertension 29 (1997) 980-985
80. Clarkson T., and Anthony M. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab 12 (1998) 589-604
81. Clarkson T., Anthony M., Williams J., et al. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc Soc Exp Biol Med 217 (1998) 365-368
82. Anthony M., Clarkson T., Bullock B., and Wagner J. Soy protein versus soy phytoestrogens in the prevention of dietinduced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17 (1997) 2524-2531
83. Peng N., White C., Roysommuti S., et al. Estrogen depletion decreases vasodilation responses in spontaneously hypertensive rats: Differing mechanism underlie the effect in aged versus young. FASEB J. 16 (2002) 468 Abstract
84. Peng N., Clark J., Wei C., and Wyss J. Estrogen depletion increases blood pressure and hypothalamic norepinephrine in middleaged spontaneously hypertensive rats. Hypertension 41 (2003) 1164-1167
85. Cho T., Peng N., Clark J., et al. Genistein attenuates the hypertensive effects of dietary NaCl in hypertensive male rats. Endocrinology 148 (2007) 5396-5402
86. Peng N., Ma W., White C., et al. Phytoestrogens preserve vascular contraction response in spontaneously hypertensive rats (SHR) on a high NaCl diet. Altern Ther Health Med. 73 (2001) 107-108 Abstract
87. Manach C., Scalbert A., Morand C., et al. Polyphenols: Food sources and bioavailability. Am J Clin Nutr. 79 (2004) 727-747
88. Rush J., Quadrilatero J., Levy A., et al. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood) 232 (2007) 814-822
89. Klatsky A. Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacol Res 55 (2007) 237-247
90. Fantinelli J., and Mosca S. Cardioprotective effects of a nonalcoholic extract of red wine during ischaemia and reperfusion in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34 (2007) 166-169
91. Karatzi K., Papamichael C., Karatzis E., et al. Red wine acutely induces favorable effects on wave reflections and central pressures in coronary artery disease patients. Am J Hypertens 18 9 Pt 1 (2005) 1161-1167
92. Pitsavos C., Makrilakis K., Panagiotakos D., et al. The Jshape effect of alcohol intake on the risk of developing acute coronary syndromes in diabetic subjects: The CARDIO2000 II Study. Diabet Med 22 (2005) 243-248
93. Peng N., Clark J., Prasain J., et al. Antihypertensive and cognitive effects of grape polyphenols in estrogendepleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 289 (2005) R771-R775
94. Wyss J., Kadish I., and van Groen T. Agerelated decline in spatial learning and memory: Attenuation by captopril. Clin Exp Hypertens 25 (2003) 455-474
95. Keung W., and Vallee B. Kudzu root: An ancient Chinese source of modern antidipsotropic agents. Phytochemistry 47 (1998) 499-506
96. Fang C., Wan X., Tan H., and Jiang C. Separation and determination of isoflavonoids in several kudzu samples by high-performance capillary electrophoresis (HPCE). Ann Chim 96 (2006) 117-124
97. Zhang Y., Zeng X., Zhang L., and Zheng X. Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med 73 (2007) 341-347
98. Kang K., Lee K., Kim S., et al. Cytoprotective effects of KIOM-79 on streptozotocin induced cell damage by inhibiting ERK and AP-1. Biol Pharm Bull 30 (2007) 852-858
99. Chen H., Yao C., Chao P., et al. Effect of serum metabolites of Pueraria lobata in rats on peripheral nerve regeneration: In vitro and in vivo studies. J Biomed Mater Res B Appl Biomater 84 (2008) 256-262
100. Sun X., Ding J., Li H., et al. Activation of large-conductance calcium-activated potassium channels by puerarin: The underlying mechanism of puerarin-mediated vasodilation. J Pharmacol Exp Ther 323 (2007) 391-397
101. Yeung D., Leung S., Xu Y., et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol 552 (2006) 105-111
102. Yan L., Chan S., Chan A., et al. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci 79 (2006) 324-330
103. Guan L., Yeung S., Huang Y., and Chen Z. Both soybean and kudzu phytoestrogens modify favorably the blood lipoprotein profile in ovariectomized and castrated hamsters. J Agric Food Chem 54 (2006) 4907-4912
104. Hsu F., Liu I., Kuo D., et al. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 66 (2003) 788-792
105. Meezan E., Meezan E., Jones K., et al. Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J Agric Food Chem 53 (2005) 8760-8767
106. Xu X., and Zhao T. Effects of puerarin on D-galactose-induced memory deficits in mice. Acta Pharmacol Sin 23 (2002) 587-590
107. Xu X., and Zhang Z. Effects of puerarin on synaptic structural modification in hippocampus of ovariectomized mice. Planta Med 73 (2007) 1047-1053